In the race against antimicrobial resistance, researchers turn to old drugs to fight persistent infections, including MRSA. Existing drugs used for other diseases may attack bacteria in new ways and be repurposed as antibiotic treatment.
Want to dig deeper into antimicrobial resistance and pandemic preparedness?
-
Article
The Fight Against Antimicrobial Resistance: International Regulatory Convergence
Read Now
Sandra Blumenrath
Global Forum -
Podcast
Time and Place for Innovation in a Pandemic Outbreak?
Listen Now
Dorothee Grimald -
Article
A Time of Optimism: Targeted Immunotherapeutics as the Long-Awaited Armamentaria Against the Scourge of Human Diseases
Read Now
Charles Oo, Robert J. Noveck
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Pandemic Preparedness: Accelerating Access to Health Products When the Global Threat Strikes: Conversations at the Inaugural DIA-CoRE Singapore Conference
Read Now
Silke Vogel, Hozanna Ngoh
Global Forum -
Podcast
Uncertainty is Certain: Pandemic Vaccine Preparedness
Listen Now
Murray Lumpkin
Want to learn more?
Plan to attend our upcoming DIA North Africa Regulatory Conference in New Cairo, Egypt, this October!
Related Perspectives
View all Deep Dives-
Article
From NPR: Scientists Find New Tricks For Old Drugs
Read Now -
Framework
From WHO: Tripartite Monitoring and Evaluation (M&E) Framework for the Global Action Plan on Antimicrobial Resistance
Read Now -
Article
From PNAS: A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus.
Read Now